SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine -- Ignore unavailable to you. Want to Upgrade?


To: Dan Dieffenwierth who wrote (3450)4/29/1998 8:14:00 PM
From: Michael Brey  Read Replies (1) | Respond to of 3906
 
From the orange county register today. Viagra has 96% of the impotency market, vvus 3% and cavaject 1% In a perfect world HVSf would have followed through over a year ago and would be in a position to capture some of viagra's patients.

Has anyone talked to the company lately? Whats out latest and greatest plan for phase II?